MedTrace Logo

Sustained Release Lidocaine for Treatment of Scrotal Pain

NCT04026945 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-10-13

No results posted yet for this study

Summary

In this study, the investigators are testing a new formulation of lidocaine for its suitability in managing chronic scrotal pain (CSCP). The new formulation ST-CP is a lidocaine sustained-release formulation and is expected to provide pain relief over 4 weeks. Currently, the drug lidocaine is not available as an injectable slow-release formulation and chronic scrotal pain patients are often left untreated.

Conditions

Interventions

DRUG

Lidocaine

Sustained-release lidocaine injection

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Ryan Flannigan, MD · University of British Columbia

  • Ryan Paterson, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2021-03-24
Completion
2021-03-24

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04026945 on ClinicalTrials.gov